Sudden withdrawal of Trump’s FDA pick left key senator fuming
Key Points:
- The White House unexpectedly withdrew Dr. Heidi Overton's nomination to lead the FDA just hours after she appeared to secure enough Senate support, surprising senior health officials and angering key senators like Bill Cassidy.
- Overton's withdrawal followed last-minute concessions to GOP holdouts, including Sen. Josh Hawley, aimed at securing crucial votes, but internal White House dynamics, particularly opposition from HHS Secretary Robert F. Kennedy Jr. and Chief of Staff Stephen Miller, undermined her candidacy.
- The move highlights deepening divides within the administration and GOP over healthcare policy, with Miller backing Kennedy’s agenda and sidelining figures like Overton who were seen as obstacles to their goals.
- Overton’s nomination was initially supported by former Chief of Staff Susie Wiles and Trump, but lost favor after Miller replaced Wiles and amid public attacks from Kennedy allies accusing Overton of prioritizing corporate interests.
- With no immediate replacement nominee, the FDA faces ongoing leadership uncertainty as acting chief Kyle Diamantas is expected to depart, and Senate Republicans may not confirm a permanent commissioner before Democrats take control in January.